162 related articles for article (PubMed ID: 33085050)
1. COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
Agostini S; Mancuso R; Costa AS; Guerini FR; Clerici M
Mol Biol Rep; 2020 Nov; 47(11):9201-9205. PubMed ID: 33085050
[TBL] [Abstract][Full Text] [Related]
2. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
3. JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients.
Agostini S; Mancuso R; Costa AS; Caputo D; Clerici M
Viruses; 2021 Mar; 13(3):. PubMed ID: 33809082
[TBL] [Abstract][Full Text] [Related]
4. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
Prezioso C; Passerini S; Limongi D; Palamara AT; Moens U; Pietropaolo V
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146876
[TBL] [Abstract][Full Text] [Related]
5. JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.
Basnyat P; Virtanen E; Elovaara I; Hagman S; Auvinen E
J Neurovirol; 2017 Oct; 23(5):734-741. PubMed ID: 28831768
[TBL] [Abstract][Full Text] [Related]
6. The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML.
Rocca A; Martelli F; Delbue S; Ferrante P; Bartolozzi D; Azzi A; Giannecchini S
J Clin Virol; 2015 Sep; 70():1-6. PubMed ID: 26305810
[TBL] [Abstract][Full Text] [Related]
7. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
8. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
9. Polyomavirus JC microRNA expression after infection in vitro.
Giovannelli I; Clausi V; Nukuzuma S; Della Malva N; Nosi D; Giannecchini S
Virus Res; 2016 Feb; 213():269-273. PubMed ID: 26763354
[TBL] [Abstract][Full Text] [Related]
10. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
11. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
Ngouth N; Monaco MC; Walker L; Corey S; Ikpeama I; Fahle G; Cortese I; Das S; Jacobson S
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746716
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract.
Link A; Balaguer F; Nagasaka T; Boland CR; Goel A
PLoS One; 2014; 9(6):e100036. PubMed ID: 24932487
[TBL] [Abstract][Full Text] [Related]
13. Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.
Giovannelli I; Martelli F; Repice A; Massacesi L; Azzi A; Giannecchini S
J Neurovirol; 2015 Dec; 21(6):666-70. PubMed ID: 25678142
[TBL] [Abstract][Full Text] [Related]
14. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
15. Viral miRNAs in plasma and urine divulge JC polyomavirus infection.
Lagatie O; Van Loy T; Tritsmans L; Stuyver LJ
Virol J; 2014 Sep; 11():158. PubMed ID: 25178457
[TBL] [Abstract][Full Text] [Related]
16. Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma.
Passerini S; Prezioso C; Prota A; Babini G; Bargiacchi L; Bartolini D; Moens U; Antonelli M; Pietropaolo V
J Neurovirol; 2023 Apr; 29(2):232-236. PubMed ID: 37097595
[TBL] [Abstract][Full Text] [Related]
17. Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.
Sharma BN; Marschall M; Rinaldo CH
Antimicrob Agents Chemother; 2014 Nov; 58(11):6724-34. PubMed ID: 25155602
[TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
19. Utility of droplet digital PCR for the quantitative detection of polyomavirus JC in clinical samples.
Giovannelli I; Ciccone N; Vaggelli G; Malva ND; Torricelli F; Rossolini GM; Giannecchini S
J Clin Virol; 2016 Sep; 82():70-75. PubMed ID: 27454232
[TBL] [Abstract][Full Text] [Related]
20. JC Polyomavirus Modifies the Expression of Human microRNAs in Progressive Multifocal Leukoencephalopathy Brain.
Honkimaa A; Suppula J; Tynninen O; Saarela M; Liimatainen H; Laine P; Auvinen P; Auvinen E
J Infect Dis; 2023 Oct; 228(7):829-833. PubMed ID: 36988117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
